Bulgaria's Sopharma Trading grows 10-mo pre-tax profit 15%

Sopharma Trading's sales revenue increased by 12% year-on-year to 715.5 million levs in the first ten months of 2020, the drug trader said in a bourse filing.

In October alone, the company's profit before taxes grew 21% to 2.2 million levs backed by a 13% increase in sales, to 76.5 million levs.

As at 11:50 CET on Friday, Sopharma Trading shares traded 1.68% lower at 5.85 levs on the Bulgarian Stock Exchange.

Sopharma Trading is a unit of Bulgarian pharmaceuticals producer Sopharma [BUL:3JR].

(1 euro = 1.95583 levs)